CHIAMAKA BABA: Open Payments
NPI 1811516834 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 34 payments from 11 companies in 2025. Trend: 2023 $499 · 2024 $464 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 17 | $348 |
| Astellas Pharma US Inc | 4 | $107 |
| Hologic Sales and Service, LLC | 3 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Ethicon US, LLC | 1 | $27 |
| Becton, Dickinson and Company | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Organon LLC | 1 | $21 |
| Baxter Healthcare | 1 | $17 |
Products named: ZURZUVAE, Veozah, MYFEMBREE, ACESSA PROVU SYSTEM, STRATAFIX, BD Onclarity, GARDASIL 9, FETAL FIBRONECTIN ENZYME IMMUNOASSAY.
Industry payments across AZ — which companies pay providers there.
